Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Mobile Smartphone Application Detects Atrial Fibrillation

By HospiMedica International staff writers
Posted on 28 Mar 2018
A new app uses the accelerometers and gyroscopes integrated into modern smartphones in order to detect cardiac activity and identify atrial fibrillation (AF).

Developed at the University of Turku (UTU; Finland) and Turku University Hospital (Finland), the smartphone mechanocardiography app uses the integrated accelerometer to detect three-dimensional (3D) linear motion, and the integrated gyroscope to detect 3D rotational motion along three axes. More...
The app then uses proprietary algorithms to analyze the micromovements in the chest and reliably determine AF.

In a blind study conducted to validate the smartphone app, the researchers compared it to visual interpretation of telemetry electrocardiographic (ECG) recordings in 300 hospitalized patients. The results showed 96% accuracy in AF identification. According to the researchers, the results are also significant in that the study group included different kinds of patients, some of whom had heart failure (HF), coronary artery disease (CAD), and ventricular extrasystole at the same time. The study was published on March 11, 2018, in Circulation.

“This is the first time that ordinary consumer electronics have achieved such reliable results that they can be actually beneficial for the patient's medical care. The results are also remarkable in that intermittent atrial fibrillation is not always detected even at the doctor's office,” said senior author Professor Juhani Airaksinen, MD, of Turku University Hospital. “If everyone can measure with an ordinary smart phone whether they have atrial fibrillation, we have the possibility to direct patients straight to the doctor and further testing without any delay. Therefore, the potential for economic savings is significant.”

AF occurs when the heart's two upper chambers beat erratically. In one form, paroxysmal AF, patients have bouts of erratic beats that begin spontaneously and usually last less than a week. AF can lead to serious adverse events such as thrombi traveling from the heart to obstruct arteries supplying the brain, causing stroke, or other parts of the body causing tissue damage.

Related Links:
University of Turku
Turku University Hospital


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
External Defibrillator
HeartSave Y | YA
Critical Care Conversion Kit
Adapter+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.